Prestige Consumer Healthcare Inc
PBH61.540USD
+1.080+1.79%
Horário de mercado （ET）Cotações atrasadas em 15 min
2.96BValor de mercado
14.73P/L TTM
Mais detalhes de Prestige Consumer Healthcare Inc Empresa
Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Informações de Prestige Consumer Healthcare Inc
Código da empresaPBH
Nome da EmpresaPrestige Consumer Healthcare Inc
Data de listagemFeb 10, 2005
CEOMr. Ronald M. (Ron) Lombardi, CPA
Número de funcionários600
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 10
Endereço660 White Plains Rd.
CidadeTARRYTOWN
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal10591
Telefone19145246800
Sitehttps://www.prestigebrands.com/
Código da empresaPBH
Data de listagemFeb 10, 2005
CEOMr. Ronald M. (Ron) Lombardi, CPA
Executivos da empresa Prestige Consumer Healthcare Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
52.39K
+4.16%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
Mr. Adel Mekhail
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
15.16K
-30.95%
Ms. Dawn M. Zier
Ms. Dawn M. Zier
Independent Director
Independent Director
14.33K
+17.11%
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Independent Director
11.33K
+22.68%
Mr. James C. D'arecca
Mr. James C. D'arecca
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
52.39K
+4.16%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
897.54M
78.89%
Rest of world
240.22M
21.11%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sex, 17 de out
Atualizado em: sex, 17 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.62%
The Vanguard Group, Inc.
11.40%
Dimensional Fund Advisors, L.P.
5.14%
Ariel Investments, LLC
4.58%
State Street Investment Management (US)
4.16%
Outro
60.10%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
14.62%
The Vanguard Group, Inc.
11.40%
Dimensional Fund Advisors, L.P.
5.14%
Ariel Investments, LLC
4.58%
State Street Investment Management (US)
4.16%
Outro
60.10%
Tipos de investidores
Investidores
Proporção
Investment Advisor
66.27%
Investment Advisor/Hedge Fund
30.99%
Research Firm
3.47%
Hedge Fund
1.89%
Pension Fund
1.33%
Individual Investor
1.29%
Sovereign Wealth Fund
1.12%
Family Office
0.61%
Bank and Trust
0.53%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
667
52.11M
108.37%
-2.03M
2025Q2
667
53.74M
109.15%
-2.00M
2025Q1
670
54.01M
109.68%
-1.79M
2024Q4
653
54.79M
110.61%
+365.71K
2024Q3
633
53.04M
107.02%
-1.71M
2024Q2
622
53.11M
106.92%
-2.21M
2024Q1
614
53.06M
106.87%
-2.26M
2023Q4
602
52.89M
106.58%
-3.51M
2023Q3
590
52.77M
106.53%
-2.81M
2023Q2
589
51.93M
104.86%
-4.95M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
7.03M
14.28%
-239.29K
-3.29%
Jun 30, 2025
The Vanguard Group, Inc.
5.62M
11.42%
-2.89K
-0.05%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.47M
5.02%
-244.43K
-9.00%
Jun 30, 2025
Ariel Investments, LLC
2.20M
4.47%
-316.61K
-12.57%
Jun 30, 2025
State Street Investment Management (US)
2.00M
4.06%
+1.65K
+0.08%
Jun 30, 2025
Macquarie Investment Management
1.97M
4%
-285.27K
-12.66%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
1.75M
3.55%
+168.12K
+10.64%
Jun 30, 2025
Allspring Global Investments, LLC
1.52M
3.09%
-94.00K
-5.82%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.41M
2.87%
+9.46K
+0.67%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
949.09K
1.93%
+534.84K
+129.11%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
Invesco Pharmaceuticals ETF
2.51%
Schwab Ariel Opportunities ETF
2.33%
SPDR S&P Pharmaceuticals ETF
2.31%
Invesco S&P SmallCap Health Care ETF
1.95%
Congress SMid Growth ETF
1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.73%
iShares U.S. Pharmaceuticals ETF
1.13%
Brandes US Small-Mid Cap Value ETF
0.86%
JPMorgan Active Small Cap Value ETF
0.72%
Invesco S&P SmallCap Low Volatility ETF
0.63%
Ver Mais
Invesco Pharmaceuticals ETF
Proporção2.51%
Schwab Ariel Opportunities ETF
Proporção2.33%
SPDR S&P Pharmaceuticals ETF
Proporção2.31%
Invesco S&P SmallCap Health Care ETF
Proporção1.95%
Congress SMid Growth ETF
Proporção1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporção1.73%
iShares U.S. Pharmaceuticals ETF
Proporção1.13%
Brandes US Small-Mid Cap Value ETF
Proporção0.86%
JPMorgan Active Small Cap Value ETF
Proporção0.72%
Invesco S&P SmallCap Low Volatility ETF
Proporção0.63%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
